Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:34:07 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:ATHX - ATHERSYS INC - http://www.athersys.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ATHX - Qnot subscribed0.0135    1.99  0.015Jan 08Nov 1615 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2023-11-16 08:30U:ATHXNews ReleaseAthersys Reports Third Quarter 2023 Financial Results and Business Highlights
2023-10-16 16:52U:ATHXNews ReleaseAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives
2023-10-10 08:30U:ATHXNews ReleaseAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
2023-10-03 16:30U:ATHXNews ReleaseAthersys Licenses its Animal Health Assets to Ardent Animal Health
2023-10-02 17:04U:ATHXNews ReleaseAthersys Director Jane Wasman Appointed Board Chair
2023-09-06 14:45U:ATHXNews ReleaseGrant Awarded to Newcastle University to Research Athersys ¢ € ™ MultiStem ‚ ® in Machine Perfusion Prior to Kidney Transplantation
2023-08-17 21:30U:ATHXNews ReleaseAthersys, Inc. Announces Pricing of $3.5 Million Public Offering
2023-08-11 08:00U:ATHXNews ReleaseAthersys Appoints Neema Mayhugh, PhD to its Board of Directors
2023-07-31 13:38U:ATHXNews ReleaseAthersys to Host Business Update Conference Call on August 9th
2023-06-01 16:40U:ATHXNews ReleasePatient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys ¢ € ™ MultiStem ‚ ® Following Hemorrhagic Trauma
2023-05-23 08:30U:ATHXNews ReleaseAthersys Restructures Debt with Supplier
2023-05-18 09:58U:ATHXNews ReleaseAthersys Reports First Quarter 2023 Financial Results and Business Highlights
2023-05-08 09:49U:ATHXNews ReleaseAthersys to Participate in Three Upcoming Conferences
2023-05-01 08:30U:ATHXNews ReleaseAthersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Conference